Bank of Nova Scotia boosted its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 29.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 4,411 shares of the biopharmaceutical company’s stock after buying an additional 1,004 shares during the period. Bank of Nova […]
Sectoral Asset Management Inc. lifted its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 0.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 22,810 shares of the biopharmaceutical company’s stock after purchasing an additional 130 shares during the quarter. Sectoral Asset Management Inc.’s holdings in Alnylam Pharmaceuticals were worth $5,421,000 at […]
Treasurer of the State of North Carolina grew its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 2.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,367 shares of the biopharmaceutical company’s stock after buying an […]
California Public Employees Retirement System raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 270,883 shares of the biopharmaceutical company’s stock after acquiring an additional 1,123 shares during the […]
State Board of Administration of Florida Retirement System lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 137,032 shares of the biopharmaceutical company’s stock after selling […]